W. Scott Butsch

1.4k total citations · 4 hit papers
41 papers, 861 citations indexed

About

W. Scott Butsch is a scholar working on Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, W. Scott Butsch has authored 41 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Pharmacology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in W. Scott Butsch's work include Pharmacology and Obesity Treatment (14 papers), Diabetes Treatment and Management (14 papers) and Obesity and Health Practices (13 papers). W. Scott Butsch is often cited by papers focused on Pharmacology and Obesity Treatment (14 papers), Diabetes Treatment and Management (14 papers) and Obesity and Health Practices (13 papers). W. Scott Butsch collaborates with scholars based in United States, France and United Kingdom. W. Scott Butsch's co-authors include Martin Kohlmeier, Kelly McCutcheon Adams, Robert F. Kushner, B. Gabriel Smolarz, Susan Alford, Joel S. Finkelstein, Mary Bouxsein, Janey S.A. Pratt, Melissa S. Putman and Elaine W Yu and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

W. Scott Butsch

38 papers receiving 835 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nutritional considerations with antiobesity medications

2024 54 citations Jaime P. Almandoz, Thomas A. Wadden et al. Obesity profile →
Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity

2024 53 citations Jeffrey I. Mechanick, W. Scott Butsch et al. Obesity Reviews profile →
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

2025 19 citations Dariush Mozaffarian, Monica Agarwal et al. American Journal of Clinical Nutrition profile →
Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

2025 17 citations Monica Agarwal, Monica Aggarwal et al. Obesity profile →

Peers

W. Scott Butsch

PHARM

PHYSI

SURGE

PHEOH

EDM

Octavia Pickett‐Blakely United States

Jacinda M. Nicklas United States

Mary Rozga United States

Nancy T. Browne United States

Joseph Nadglowski United States

Audrina J. Bunton United States

Lisa K. Diewald United States

Suzanne Pearson Australia

Cindy Guandalini United States

Penny Gordon-Larsen United States

Octavia Pickett‐Blakely United States

W. Scott Butsch

177 ×0.6

PHARM

161 ×0.6

PHYSI

223 ×0.9

SURGE

150 ×0.7

PHEOH

154 ×1.0

EDM

Citations per year, relative to W. Scott Butsch W. Scott Butsch (= 1×) peers Octavia Pickett‐Blakely

Countries citing papers authored by W. Scott Butsch

Since Specialization

Citations

This map shows the geographic impact of W. Scott Butsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Scott Butsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Scott Butsch more than expected).

Fields of papers citing papers by W. Scott Butsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Scott Butsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Scott Butsch. The network helps show where W. Scott Butsch may publish in the future.

Co-authorship network of co-authors of W. Scott Butsch

This figure shows the co-authorship network connecting the top 25 collaborators of W. Scott Butsch. A scholar is included among the top collaborators of W. Scott Butsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Scott Butsch. W. Scott Butsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gasoyan, Hamlet, W. Scott Butsch, H. Renner, et al.. (2025). Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice. Obesity. 33(12). 2296–2303. 1 indexed citations

Gasoyan, Hamlet, Alexander Zajichek, James Bena, et al.. (2025). Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity. Nature Medicine. 31(10). 3341–3349. 1 indexed citations

Mozaffarian, Dariush, Monica Agarwal, Monica Aggarwal, et al.. (2025). Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. PubMed. 15. 100181–100181. 7 indexed citations

Gasoyan, Hamlet, W. Scott Butsch, Phuc Le, et al.. (2025). Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status. Obesity. 33(9). 1657–1667. 9 indexed citations

Mozaffarian, Dariush, Monica Agarwal, Monica Aggarwal, et al.. (2025). Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition. 122(1). 344–367. 19 indexed citations breakdown →

Butsch, W. Scott, Suela Sulo, Amelia Chang, et al.. (2025). Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study. PubMed. 15. 100186–100186. 10 indexed citations

Gasoyan, Hamlet, et al.. (2024). One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice. JAMA Network Open. 7(9). e2433326–e2433326. 25 indexed citations

Krishnan, Arunkumar, Carolin V. Schneider, Hendrik‐Tobias Arkenau, et al.. (2024). Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study. Journal of Clinical & Translational Endocrinology. 38. 100370–100370. 2 indexed citations

Seeholzer, Eileen, et al.. (2024). Preclinical obesity curriculum: audit, implementation, and evaluation. BMC Medical Education. 24(1). 639–639. 2 indexed citations

10.

Almandoz, Jaime P., Thomas A. Wadden, Colleen Tewksbury, et al.. (2024). Nutritional considerations with antiobesity medications. Obesity. 32(9). 1613–1631. 54 indexed citations breakdown →

11.

Mechanick, Jeffrey I., W. Scott Butsch, Sandra Christensen, et al.. (2024). Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity. Obesity Reviews. 26(1). e13841–e13841. 53 indexed citations breakdown →

12.

Stanford, Fatima Cody, et al.. (2023). Obesity in the USMLE Step 1 examination: A call to action. International Journal of Obesity. 47(7). 642–643. 3 indexed citations

13.

Yurista, Salva R., Shi Chen, Thomas Garrett, et al.. (2023). Mapping the Unseen: In Vivo CEST-MRI of Creatine Reveals Improved Cardiac Energetics in Subjects with Obesity Following Bariatric Surgery. Obesity Surgery. 33(6). 1944–1948. 2 indexed citations

14.

Butsch, W. Scott, et al.. (2023). Obesity preclinical elective: a qualitative thematic analysis of student feedback. International Journal of Obesity. 48(1). 78–82. 2 indexed citations

15.

Matza, Louis S., et al.. (2022). Health state utilities associated with hyperphagia: Data for use in cost‐utility models. Obesity Science & Practice. 9(4). 376–382. 2 indexed citations

16.

Morey‐Vargas, Oscar L., Ali Aminian, Karen Steckner, et al.. (2022). Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations. Surgery for Obesity and Related Diseases. 18(8). 1087–1101. 6 indexed citations

17.

Butsch, W. Scott, Alexandra M. Hajduk, Michelle I. Cardel, et al.. (2021). COVID‐19 vaccines are effective in people with obesity: A position statement from The Obesity Society. Obesity. 29(10). 1575–1579. 35 indexed citations

18.

Aminian, Ali, Chao Tu, W. Scott Butsch, et al.. (2020). Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity. Surgery for Obesity and Related Diseases. 17(1). 208–214. 39 indexed citations

19.

Ahmad, Nadia N., et al.. (2016). Clinical Management of Obesity in Women. Obstetrics and Gynecology Clinics of North America. 43(2). 201–230. 8 indexed citations

20.

Butsch, W. Scott. (2015). Obesity medications. Current Opinion in Endocrinology Diabetes and Obesity. 22(5). 360–366. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact